Top Banner
Monitoring Residual Myeloma High-Resolution Serum/Urine Electrophoresis or Marrow Biopsy With Immunohistochemical Analysis? Vanessa Agudelo Vásquez ID: 000170813 María Mercedes Barros Daza ID: 000170833 3rd Semester Medicine Amanda D. Tatsas, MD, Madan H. Jagasia, MBBS, MS, Heidi Chen, PhD, and Thomas L. McCurley, MD. American Society for Clinical Pathology
22

Seminario molecular

Jul 03, 2015

Download

Health & Medicine

mariabarros14

Presentado por: Vanessa Agudelo V
y Maria Mercedes Barros Daza.

Biologia Molecular
Welcome message from author
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
Page 1: Seminario molecular

Monitoring Residual MyelomaHigh-Resolution Serum/Urine Electrophoresis or Marrow

Biopsy With Immunohistochemical Analysis?

Vanessa Agudelo Vásquez ID: 000170813

María Mercedes Barros Daza ID: 000170833

3rd Semester

Medicine

Amanda D. Tatsas, MD, Madan H. Jagasia, MBBS, MS, Heidi Chen, PhD, and Thomas L. McCurley, MD.

American Society for Clinical Pathology

Page 2: Seminario molecular

INTRODUCTION

MARROW BIOPSY

A bone marrow biopsy is the removal of soft tissue, called marrow, from inside bone. Bone marrow is found in the hollow part of most bones. It helps form blood cells.

Page 3: Seminario molecular

ELECTROPHORESIS

Electrophoresis is a separations technique that is based on the mobility of ions in an electric field.

Page 4: Seminario molecular

IMMUNOHISTOCHEMICAL ANALYSIS

Structural and morphological studies of tissues.

Page 5: Seminario molecular
Page 6: Seminario molecular

GENERAL OBJETIVE

This study to compare the detection of residual MM in BM biopsy specimens with immunoperoxidase staining with noninvasive studies by SPE and UPE in routine patient follow-up and show that SPE and UPE are sensitive and effective methods to detect residual disease, and negative results for both can obviate the need for a BM biopsy.

Page 7: Seminario molecular

MATERIALES Y METODOS

83 Biopsias: Mayo 2006 a

Diciembre 2006

47 Hombres 36 Mujeres

EM: 53 años Tiempo transcurrido: 561 días (rango, 17-2,750 días)

Muestra

RESULTADO

•SPE•UPE•Médula ósea

•Ig monoclonal pesada

•Cadenas ligeras (K – L)

Page 8: Seminario molecular

INMUNOHISTOQUIMICA: Identificación de un tejido por medio de la interacción de un antígeno con un anticuerpo (marcado). La célula se colorea para demostrar la relación y localización de un molécula de interés.

INMUNOFIJACIÒN: Es una técnica de laboratorio que se utiliza para identificar proteínas o anticuerpos en la sangre, suero y orina.

MATERIALES Y METODOS

CP: Cadenas pesadas (G- A- M – D – E)

Cadenas ligeras: (K- L)

Page 9: Seminario molecular

•Diagnóstico de la SPE MM: PSE y UPE para cada paciente.

•Posterior al diagnóstico: UPE en el momento de la biopsia de seguimiento para el monitoreo de Mieloma múltiple.

células plasmáticas con CD138 (Syndecan-1)

Manchas κ y λ en la cadena ligera

MATERIALES Y METODOS

Page 10: Seminario molecular

MATERIALES Y METODOSMétodos

•Las manchas H & E y de histoquímica fueron revisadas por (2) patólogos (ADT y TLM)

•Se utilizó la plataforma DAKO para el análisis inmunohistoquímica de BM, κ, λ, y CD138

•Técnicas del sistema de inmunofijación Helena SPIFE .

Page 11: Seminario molecular

RELACION

INMUNOHISTOQUIMICA

65 casos de análisis inmunohistoquímica con células plasmáticas con

CD138 (Syndecan-1)

INMUNOFIJACIÒN

Manchas κ y λ en la cadena ligera

Page 12: Seminario molecular

RESULTADOS

Page 13: Seminario molecular

RESULTADOS

Page 14: Seminario molecular

IMAGEN 1: UPE

RESULTADOS

Page 15: Seminario molecular

Conclusión: El método UPE no invasivo ( sedimento urinario) es igual de efectivo a la biopsia que es invasivo.

Page 16: Seminario molecular

IMAGEN 2: SPE

RESULTADOS

Page 17: Seminario molecular

Conclusión: La técnica no invasiva de análisis del suero, es mas efectiva porque detectó en mayor cantidad las proteínas monoclonales que lo detectado por inmunohistoquímica con los CD138 en la biopsia de medula ósea.

Page 18: Seminario molecular

AUTHOR SAID YES OR NOT

Rasmussen T, et al. A variety of methods for monitoring disease activity are

available.

yes

Owen RG et, al. The use of multiple consensus primers allows detection of a clone in 80% of patients but

increases cost.

yes

Jaskowski TD et, al. κ and λ FLC assays are more sensitive than IFX but are less

specific.

yes

Catrou PG, May TA et, al.

Because the money spent on health care in the United States increases exponentially, cost-

effectiveness is becoming increasingly important to the

practice of health care.

yes

DISCUSSION

Page 19: Seminario molecular

1. The use of Immunohistochemical techniques generate changes in the physiology of conception and health and disease.

3. The analysis obtained by the interaction of antigen and antibody allows a firm diagnosis of MM.

5. For the diagnosis of multiple myeloma, non-invasive techniques exist to facilitate the knowledge of the results without painful procedures to patients.

4. These studies contribute to the diagnosis currently effective, timely and accurate cancer, possibly reducing deaths.

Page 20: Seminario molecular

MAPA CONCEPTUAL : Vanessa Agudelo Vásquez

Page 21: Seminario molecular

MAPA CONCEPTUAL : María Mercedes Barros Daza

Page 22: Seminario molecular